Healthcare

Cancer patients who otherwise would shy away from visiting the gym because of an altered appearance and lack of confidence are thriving as a result of an innovative 12-week exercise program.

On 7-11th October, the European Society for Medical Oncology (ESMO) Annual Meeting will take place in Copenhagen, Denmark.

Ipsos Healthcare has launched its Nonalcoholic Steatohepatitis (NASH) Therapy Monitor in the US and EU5 initially – France, Germany, Italy, Spain, and UK – with other markets available on demand.

Connected Health – sometimes referred to as Digital Health – is a potential game-changer for global healthcare.

Ipsos Healthcare – the global healthcare division of Ipsos – has launched the syndicated PD-L1 Testing Monitor, a timely addition to the Ipsos Oncology Molecular Diagnostics Portfolio.

Non-alcoholic Steatohepatitis, or NASH, is a liver disease characterized by rising prevalence, low diagnosis and a lack of therapies approved for treatment. All of these factors combine to make NASH a priority for the healthcare industry – and, potentially, a multi-billion-dollar market. Accordingly, the race is now on among several pharma companies to develop the first effective pharmacotherapy to treat NASH.

This study looks at awareness and perceptions of Pneumonia among the 50+ population in nine European markets.

A recent survey on Chinese outbound tourism showed that more than a third of Chinese tourists considered travel as important as love and marriage, family wealth, career development, learning and education, healthcare, and child growth.

What is driving the Healthcare Market in ASEAN? Stay tuned to receive more interesting information on ASEAN's healthcare industry next week!